Package 81864-102-30

Brand: ojjaara

Generic: momelotinib
NDC Package

Package Facts

Identity

Package NDC 81864-102-30
Digits Only 8186410230
Product NDC 81864-102
Description

30 TABLET in 1 BOTTLE (81864-102-30)

Marketing

Marketing Status
Marketed Since 2023-09-15
Brand ojjaara
Generic momelotinib
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "26b81ffa-710b-4a24-abc8-0255797add74", "openfda": {"upc": ["0381864103305", "0381864102308", "0381864101301"], "unii": ["LDX8893L5D"], "rxcui": ["2665210", "2665216", "2665218", "2665220", "2665222", "2665224"], "spl_set_id": ["4a672fd1-eb7b-4aa9-9b23-845e4b5dc400"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (81864-102-30)", "package_ndc": "81864-102-30", "marketing_start_date": "20230915"}], "brand_name": "Ojjaara", "product_id": "81864-102_26b81ffa-710b-4a24-abc8-0255797add74", "dosage_form": "TABLET", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Kinase Inhibitors [MoA]"], "product_ndc": "81864-102", "generic_name": "Momelotinib", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ojjaara", "active_ingredients": [{"name": "MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE", "strength": "150 mg/1"}], "application_number": "NDA216873", "marketing_category": "NDA", "marketing_start_date": "20230915", "listing_expiration_date": "20261231"}